Shares of GENinCode Plc (LON:GENI – Get Free Report) hit a new 52-week low during trading on Friday . The stock traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.40 ($0.04), with a volume of 59570 shares. The stock had previously closed at GBX 3.60 ($0.04).
GENinCode Price Performance
The stock has a market cap of £6.02 million, a price-to-earnings ratio of -68.00 and a beta of 0.66. The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89. The stock’s 50 day simple moving average is GBX 3.97 and its two-hundred day simple moving average is GBX 5.38.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- 5 Top Rated Dividend Stocks to Consider
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Most Effectively Use the MarketBeat Earnings Screener
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
